This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Investigations

Authoring team

The investigation of allergic bronchopulmonary aspergillosis should include the following: (1)

  • chest X-ray; shows various transient abnormalities:
    • consolidation or collapse
    • thickened bronchial wall markings
    • peripheral shadows
    • signs of proximal bronchiectasis
  • full blood count; reveals eosinophilia. (A total eosinophil count of over 500 is one of the diagnostic criteria for ABPA in patients with asthma). (2)
  • serum IgE levels will be raised and precipitating antibodies to Aspergillus species present in 90% of cases. Note - the combination of elevated total serum IgE and elevated specific IgE to recombinant Aspergillus allergen f4 and/or recombinant Aspergillus allergen f6 allows classic ABPA to be diagnosed with 100% specificity and 64% sensitivity, and with a 100% positive predictive value and 94% negative predictive value. (3)
  • fungal spores or hyphae may be seen on sputum microscopy or grown on culture
  • skin-prick test; the sensitivity of Aspergillus skin testing for ABPA is very high (>95% in prior studies), but the specificity is relatively low. Only 25% to 37% of patients with a positive Aspergillus skin test end up meeting the full criteria for ABPA. (4)

 

  • high-resolution CT of the chest; might be ordered to assess for characteristic radiographic findings of ABPA. (5) This can show up high-attenuation mucus (mucus which is visually denser than paraspinal skeletal muscle) and which is considered the closest things to a pathognomonic sign for ABPA, with 100% specificity. When present at the time of diagnosis it also predicts poor outcomes. (6)

References

  1. Patterson TF et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Aug 15;63(4):e1-e60
  2. Agarwal R, Saxena P, Muthu V, et al. Evaluation of simpler criteria for diagnosing allergic bronchopulmonary aspergillosis complicating asthma. Front Cell Infect Microbiol. 2022;12:861866.
  3. Casaulta C, Fluckiger S, Crameri R, et al. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr Allergy Immunol. 2005;16:217-225.
  4. Shah A, Panjabi C. Allergic aspergillosis of the respiratory tract. Eur Respir Rev. 2014 Mar 1;23(131):8-29.
  5. Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013 Aug;43(8):850-73.
  6. Agarwal R, Maskey D, Aggarwal AN, et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS One. 2013;8(4):e61105.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2026 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.